{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:07:25Z","timestamp":1761919645698},"reference-count":244,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.micpath.2012.12.002","type":"journal-article","created":{"date-parts":[[2012,12,17]],"date-time":"2012-12-17T16:39:59Z","timestamp":1355762399000},"page":"2-16","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Vaccination against tuberculosis: How can we better BCG?"],"prefix":"10.1016","volume":"58","author":[{"given":"Jonathan M.","family":"Pitt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Blankley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"McShane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"O'Garra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2012.12.002_bib1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1146\/annurev.immunol.22.012703.104635","article-title":"Immunity to tuberculosis","volume":"22","author":"North","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib2","first-page":"221","article-title":"Die aetiologie der tuberculose","volume":"19","author":"Koch","year":"1882","journal-title":"Berliner Klinische Wochenschrift"},{"key":"10.1016\/j.micpath.2012.12.002_bib3","series-title":"Global tuberculosis control","author":"W.H.O","year":"2011"},{"key":"10.1016\/j.micpath.2012.12.002_bib4","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib5","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nri1704","article-title":"Tuberculosis control in the era of HIV","volume":"5","author":"Nunn","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(10)62173-3","article-title":"Tuberculosis","volume":"378","author":"Lawn","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.micpath.2012.12.002_bib7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.chom.2009.02.004","article-title":"Taming tuberculosis: a challenge for science and society","volume":"5","author":"Nathan","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.micpath.2012.12.002_bib8","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.micpath.2012.12.002_bib9","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.micpath.2012.12.002_bib10","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0140-6736(06)68392-X","article-title":"WHO's new stop TB strategy","volume":"367","author":"Raviglione","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.micpath.2012.12.002_bib11","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1172\/JCI34614","article-title":"Confronting the scientific obstacles to global control of tuberculosis","volume":"118","author":"Young","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.micpath.2012.12.002_bib12","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1056\/NEJM199612263352604","article-title":"Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection","volume":"335","author":"Jouanguy","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib13","first-page":"193","article-title":"Revised BCG vaccination guidelines for infants at risk for HIV infection","volume":"82","author":"W.H.O","year":"2007","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.micpath.2012.12.002_bib14","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.282.7.677","article-title":"Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO global surveillance and monitoring project","volume":"282","author":"Dye","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.micpath.2012.12.002_bib15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.tim.2009.02.005","article-title":"Eliminating latent tuberculosis","volume":"17","author":"Young","year":"2009","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.micpath.2012.12.002_bib16","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrmicro2236","article-title":"The spectrum of latent tuberculosis: rethinking the biology and intervention strategies","volume":"7","author":"Barry","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.micpath.2012.12.002_bib17","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1126\/science.8303277","article-title":"Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase","volume":"263","author":"Sturgill-Koszycki","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.micpath.2012.12.002_bib18","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1084\/jem.134.3.713","article-title":"Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes","volume":"134","author":"Armstrong","year":"1971","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.immuni.2007.12.010","article-title":"Macrophage and T cell dynamics during the development and disintegration of mycobacterial granulomas","volume":"28","author":"Egen","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.micpath.2012.12.002_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.immunol.19.1.93","article-title":"Immunology of tuberculosis","volume":"19","author":"Flynn","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.it.2011.10.003","article-title":"Neutrophils in tuberculosis: friend or foe?","volume":"33","author":"Lowe","year":"2011","journal-title":"Trends Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib22","doi-asserted-by":"crossref","first-page":"7110","DOI":"10.4049\/jimmunol.1100001","article-title":"Lung neutrophils facilitate activation of naive antigen-specific CD4+ T cells during Mycobacterium tuberculosis infection","volume":"186","author":"Blomgran","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib23","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1378\/chest.09-0903","article-title":"Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB","volume":"137","author":"Eum","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.micpath.2012.12.002_bib24","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1128\/IAI.73.3.1744-1753.2005","article-title":"Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice","volume":"73","author":"Eruslanov","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2012.12.002_bib25","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1128\/IAI.00057-06","article-title":"Genetically determined susceptibility to tuberculosis in mice causally involves accelerated and enhanced recruitment of granulocytes","volume":"74","author":"Keller","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2012.12.002_bib26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/3-540-32636-7_2","article-title":"Dendritic cells: translating innate to adaptive immunity","volume":"311","author":"Steinman","year":"2006","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-immunol-100311-102839","article-title":"Decisions about dendritic cells: past, present, and future","volume":"30","author":"Steinman","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib28","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.4049\/jimmunol.179.4.2509","article-title":"Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in\u00a0vivo","volume":"179","author":"Wolf","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib29","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.micinf.2005.12.023","article-title":"A\u00a0role for dendritic cells in the dissemination of mycobacterial infection","volume":"8","author":"Humphreys","year":"2006","journal-title":"Microbe Infect"},{"key":"10.1016\/j.micpath.2012.12.002_bib30","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev.immunol.021908.132703","article-title":"Cell-mediated immune responses in tuberculosis","volume":"27","author":"Cooper","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1084\/jem.193.3.271","article-title":"The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice","volume":"193","author":"Mogues","year":"2001","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib32","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4049\/jimmunol.138.1.293","article-title":"The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis","volume":"138","author":"Orme","year":"1987","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1084\/jem.192.3.347","article-title":"Depletion of CD4 (+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2","volume":"192","author":"Scanga","year":"2000","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib34","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1128\/IAI.01126-10","article-title":"HIV-1\/mycobacterium tuberculosis coinfection immunology: how does HIV-1 exacerbate tuberculosis?","volume":"79","author":"Diedrich","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2012.12.002_bib35","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/path.1628","article-title":"Human tuberculous granulomas induce peripheral lymphoid follicle-like structures to orchestrate local host defence in the lung","volume":"204","author":"Ulrichs","year":"2004","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.micpath.2012.12.002_bib36","doi-asserted-by":"crossref","first-page":"e1002052","DOI":"10.1371\/journal.ppat.1002052","article-title":"A\u00a0gamma interferon independent mechanism of CD4 T cell mediated control of M. tuberculosis infection in\u00a0vivo","volume":"7","author":"Gallegos","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.micpath.2012.12.002_bib37","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1126\/science.8456300","article-title":"Multiple defects of immune cell function in mice with disrupted interferon-gamma genes","volume":"259","author":"Dalton","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.micpath.2012.12.002_bib38","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.chom.2010.06.002","article-title":"Mycobacterium tuberculosis wears what it eats","volume":"8","author":"Russell","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.micpath.2012.12.002_bib39","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1128\/IAI.69.3.1722-1728.2001","article-title":"Temporal and spatial arrangement of lymphocytes within lung granulomas induced by aerosol infection with Mycobacterium tuberculosis","volume":"69","author":"Gonzalez-Juarrero","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2012.12.002_bib40","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/ni.1781","article-title":"Foamy macrophages and the progression of the human tuberculosis granuloma","volume":"10","author":"Russell","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib41","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nri3211","article-title":"Revisiting the role of the granuloma in tuberculosis","volume":"12","author":"Ramakrishnan","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib42","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.1128\/IAI.00592-09","article-title":"Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model","volume":"77","author":"Lin","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2012.12.002_bib43","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1126\/science.285.5428.732","article-title":"Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors","volume":"285","author":"Brightbill","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.micpath.2012.12.002_bib44","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.4049\/jimmunol.163.7.3920","article-title":"Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis","volume":"163","author":"Means","year":"1999","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib45","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-065X.2007.00545.x","article-title":"Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter?","volume":"219","author":"Berrington","year":"2007","journal-title":"Immunol Rev"},{"key":"10.1016\/j.micpath.2012.12.002_bib46","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1084\/jem.20051782","article-title":"TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis","volume":"202","author":"Bafica","year":"2005","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib47","doi-asserted-by":"crossref","first-page":"20961","DOI":"10.1074\/jbc.M411379200","article-title":"Mycobacterium tuberculosis heat shock proteins use diverse Toll-like receptor pathways to activate pro-inflammatory signals","volume":"280","author":"Bulut","year":"2005","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.micpath.2012.12.002_bib48","doi-asserted-by":"crossref","first-page":"405310","DOI":"10.1155\/2011\/405310","article-title":"Innate immune recognition of Mycobacterium tuberculosis","volume":"2011","author":"Kleinnijenhuis","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib49","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1084\/jem.20021229","article-title":"Mycobacteria target DC-SIGN to suppress dendritic cell function","volume":"197","author":"Geijtenbeek","year":"2003","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib50","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/ni.1778","article-title":"Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori","volume":"10","author":"Gringhuis","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib51","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1182\/blood-2006-05-024406","article-title":"The beta-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria","volume":"108","author":"Yadav","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.micpath.2012.12.002_bib52","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.4049\/jimmunol.0904013","article-title":"cutting edge: mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate","volume":"184","author":"Schoenen","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib53","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1084\/jem.20081445","article-title":"Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRgamma-Syk-Card9-dependent innate immune activation","volume":"206","author":"Werninghaus","year":"2009","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib54","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1084\/jem.20091750","article-title":"Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle","volume":"206","author":"Ishikawa","year":"2009","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib55","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10067-010-1605-1","article-title":"Tuberculosis and anti-TNF treatment: experience of a central London hospital","volume":"30","author":"Mankia","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.micpath.2012.12.002_bib56","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.4049\/jimmunol.162.6.3504","article-title":"Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin","volume":"162","author":"Bean","year":"1999","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib57","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/1074-7613(95)90001-2","article-title":"Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice","volume":"2","author":"Flynn","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.micpath.2012.12.002_bib58","doi-asserted-by":"crossref","first-page":"6846","DOI":"10.4049\/jimmunol.172.11.6846","article-title":"TNF influences chemokine expression of macrophages in\u00a0vitro and that of CD11b+ cells in\u00a0vivo during Mycobacterium tuberculosis infection","volume":"172","author":"Algood","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib59","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1128\/IAI.01011-07","article-title":"Tumor necrosis factor blockade in chronic murine tuberculosis enhances granulomatous inflammation and disorganizes granulomas in the lungs","volume":"76","author":"Chakravarty","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2012.12.002_bib60","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1128\/IAI.69.3.1847-1855.2001","article-title":"Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology","volume":"69","author":"Mohan","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2012.12.002_bib61","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/art.27271","article-title":"Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model","volume":"62","author":"Lin","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.micpath.2012.12.002_bib62","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.4049\/jimmunol.179.2.1178","article-title":"IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection","volume":"179","author":"Fremond","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib63","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.4049\/jimmunol.0904189","article-title":"Caspase-1 independent IL-1beta production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in\u00a0vivo","volume":"184","author":"Mayer-Barber","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib64","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.immuni.2011.12.002","article-title":"Innate and adaptive interferons suppress IL-1alpha and IL-1beta production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection","volume":"35","author":"Mayer-Barber","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.micpath.2012.12.002_bib65","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1084\/jem.20052302","article-title":"Tuberculosis in children and adults: two distinct genetic diseases","volume":"202","author":"Alcais","year":"2005","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib66","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev.immunol.20.081501.125851","article-title":"Genetic dissection of immunity to mycobacteria: the human model","volume":"20","author":"Casanova","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib67","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1126\/science.8097338","article-title":"Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages","volume":"260","author":"Hsieh","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.micpath.2012.12.002_bib68","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.4049\/jimmunol.154.10.5071","article-title":"Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells","volume":"154","author":"Macatonia","year":"1995","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib69","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri1001","article-title":"Interleukin-12 and the regulation of innate resistance and adaptive immunity","volume":"3","author":"Trinchieri","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib70","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/ni0909-929","article-title":"From IL-10 to IL-12: how pathogens and their products stimulate APCs to induce T(H)1 development","volume":"10","author":"O'Garra","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib71","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/0923-2494(96)83017-3","article-title":"The role of macrophage- and dendritic cell-derived IL12 in Th1 phenotype development","volume":"146","author":"O'Garra","year":"1995","journal-title":"Res Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib72","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1084\/jem.194.3.343","article-title":"A\u00a0critical role for interleukin 18 in primary and memory effector responses to Listeria monocytogenes that extends beyond its effects on Interferon gamma production","volume":"194","author":"Neighbors","year":"2001","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib73","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1086\/422534","article-title":"Association of IL12RB1 polymorphisms with pulmonary tuberculosis in adults in Morocco","volume":"190","author":"Remus","year":"2004","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.micpath.2012.12.002_bib74","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0167-5699(98)01321-8","article-title":"Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria","volume":"19","author":"Ottenhoff","year":"1998","journal-title":"Immunol Today"},{"key":"10.1016\/j.micpath.2012.12.002_bib75","doi-asserted-by":"crossref","first-page":"e6984","DOI":"10.1371\/journal.pone.0006984","article-title":"Immunomodulation with recombinant interferon-gamma1b in pulmonary tuberculosis","volume":"4","author":"Dawson","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2012.12.002_bib76","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1089\/jir.2006.0103","article-title":"IFN-gamma therapy of tuberculosis and related infections","volume":"27","author":"Reljic","year":"2007","journal-title":"J\u00a0Interferon Cytokine Res"},{"key":"10.1016\/j.micpath.2012.12.002_bib77","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1084\/jem.186.1.39","article-title":"Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis","volume":"186","author":"Cooper","year":"1997","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib78","first-page":"423","article-title":"The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection","volume":"84","author":"Cooper","year":"1995","journal-title":"Immunology"},{"key":"10.1016\/j.micpath.2012.12.002_bib79","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.4049\/jimmunol.155.5.2515","article-title":"IL-12 increases resistance of BALB\/c mice to Mycobacterium tuberculosis infection","volume":"155","author":"Flynn","year":"1995","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib80","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.4049\/jimmunol.168.3.1322","article-title":"Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present","volume":"168","author":"Cooper","year":"2002","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib81","doi-asserted-by":"crossref","first-page":"6957","DOI":"10.4049\/jimmunol.167.12.6957","article-title":"A\u00a0protective and agonistic function of IL-12p40 in mycobacterial infection","volume":"167","author":"Holscher","year":"2001","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib82","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1084\/jem.20052545","article-title":"Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection","volume":"203","author":"Khader","year":"2006","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib83","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.4049\/jimmunol.160.3.1290","article-title":"Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages","volume":"160","author":"Schaible","year":"1998","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib84","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1084\/jem.178.6.2243","article-title":"Disseminated tuberculosis in interferon gamma gene-disrupted mice","volume":"178","author":"Cooper","year":"1993","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib85","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection","volume":"178","author":"Flynn","year":"1993","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib86","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1084\/jem.178.4.1435","article-title":"Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide","volume":"178","author":"Kamijo","year":"1993","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib87","doi-asserted-by":"crossref","first-page":"5243","DOI":"10.1073\/pnas.94.10.5243","article-title":"Identification of nitric oxide synthase as a protective locus against tuberculosis","volume":"94","author":"MacMicking","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micpath.2012.12.002_bib88","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.1128\/IAI.69.12.7711-7717.2001","article-title":"The inducible nitric oxide synthase locus confers protection against aerogenic challenge of both clinical and laboratory strains of Mycobacterium tuberculosis in mice","volume":"69","author":"Scanga","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2012.12.002_bib89","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1128\/IAI.68.3.1231-1234.2000","article-title":"Transient loss of resistance to pulmonary tuberculosis in p47(phox-\/-) mice","volume":"68","author":"Cooper","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2012.12.002_bib90","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cyto.2007.11.022","article-title":"IL-23 and IL-17 in tuberculosis","volume":"41","author":"Khader","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.micpath.2012.12.002_bib91","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJMra0707449","article-title":"Interleukin-17 and type 17 helper T cells","volume":"361","author":"Miossec","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib92","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.coi.2007.07.004","article-title":"Interleukin-12 and tuberculosis: an old story revisited","volume":"19","author":"Cooper","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib93","doi-asserted-by":"crossref","first-page":"788","DOI":"10.4049\/jimmunol.175.2.788","article-title":"IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available","volume":"175","author":"Khader","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib94","doi-asserted-by":"crossref","first-page":"8684","DOI":"10.4049\/jimmunol.177.12.8684","article-title":"Interleukin-23 restores immunity to Mycobacterium tuberculosis infection in IL-12p40-deficient mice and is not required for the development of IL-17-secreting T cell responses","volume":"177","author":"Wozniak","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib95","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nm1710","article-title":"IL-22 mediates mucosal host defense against gram-negative bacterial pneumonia","volume":"14","author":"Aujla","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib96","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.smim.2007.10.009","article-title":"Th17 cells and mucosal host defense","volume":"19","author":"Aujla","year":"2007","journal-title":"Semin Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib97","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.4049\/jimmunol.1101377","article-title":"IL-23 is required for long-term control of Mycobacterium tuberculosis and B cell follicle formation in the infected lung","volume":"187","author":"Khader","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib98","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.4049\/jimmunol.178.6.3786","article-title":"IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection","volume":"178","author":"Umemura","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib99","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.4049\/jimmunol.0903332","article-title":"Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung","volume":"184","author":"Okamoto Yoshida","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib100","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.4049\/jimmunol.177.7.4662","article-title":"IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection","volume":"177","author":"Lockhart","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib101","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ni1449","article-title":"IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge","volume":"8","author":"Khader","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib102","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/eji.201141569","article-title":"IL-23-dependent IL-17 drives Th1-cell responses following Mycobacterium bovis BCG vaccination","volume":"42","author":"Gopal","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib103","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1128\/IAI.00287-09","article-title":"Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis","volume":"77","author":"Vordermeier","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2012.12.002_bib104","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1128\/IAI.68.3.1706-1709.2000","article-title":"Effective preexposure tuberculosis vaccines fail to protect when they are given in an immunotherapeutic mode","volume":"68","author":"Turner","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2012.12.002_bib105","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1084\/jem.20100265","article-title":"Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis","volume":"207","author":"Cruz","year":"2010","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib106","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib107","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nri2097","article-title":"T(H)1 cells control themselves by producing interleukin-10","volume":"7","author":"O'Garra","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib108","doi-asserted-by":"crossref","first-page":"798","DOI":"10.4049\/jimmunol.157.2.798","article-title":"In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha","volume":"157","author":"Gazzinelli","year":"1996","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib109","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.4049\/jimmunol.158.7.3311","article-title":"IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi","volume":"158","author":"Hunter","year":"1997","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib110","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1128\/IAI.67.9.4435-4442.1999","article-title":"A\u00a0defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice","volume":"67","author":"Li","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2012.12.002_bib111","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.4049\/jimmunol.158.5.2259","article-title":"Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice","volume":"158","author":"Dai","year":"1997","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib112","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1084\/jem.194.10.1497","article-title":"The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure","volume":"194","author":"Belkaid","year":"2001","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib113","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1128\/IAI.70.11.6284-6293.2002","article-title":"Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy","volume":"70","author":"Murray","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2012.12.002_bib114","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/nm1492","article-title":"Interleukin-10 determines viral clearance or persistence in\u00a0vivo","volume":"12","author":"Brooks","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib115","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1084\/jem.20061462","article-title":"Resolution of a chronic viral infection after interleukin-10 receptor blockade","volume":"203","author":"Ejrnaes","year":"2006","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib116","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1365-2567.2003.01645.x","article-title":"Increased interleukin-10 expression is not responsible for failure of T helper 1 immunity to resolve airborne Mycobacterium tuberculosis infection in mice","volume":"109","author":"Jung","year":"2003","journal-title":"Immunology"},{"key":"10.1016\/j.micpath.2012.12.002_bib117","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1046\/j.1365-2249.1998.00636.x","article-title":"Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis","volume":"113","author":"North","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib118","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.tube.2009.01.001","article-title":"Lack of IL-10 alters inflammatory and immune responses during pulmonary Mycobacterium tuberculosis infection","volume":"89","author":"Higgins","year":"2009","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.micpath.2012.12.002_bib119","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1128\/IAI.67.6.3087-3095.1999","article-title":"Increased antimycobacterial immunity in interleukin-10-deficient mice","volume":"67","author":"Murray","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2012.12.002_bib120","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-3083.2001.00952.x","article-title":"Endogenous inhibition of antimycobacterial immunity by IL-10 varies between mycobacterial species","volume":"54","author":"Roach","year":"2001","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib121","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4049\/jimmunol.158.1.315","article-title":"T\u00a0cell-derived IL-10 antagonizes macrophage function in mycobacterial infection","volume":"158","author":"Murray","year":"1997","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib122","doi-asserted-by":"crossref","first-page":"6343","DOI":"10.4049\/jimmunol.169.11.6343","article-title":"In\u00a0vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL\/6 mice","volume":"169","author":"Turner","year":"2002","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib123","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.4049\/jimmunol.181.8.5545","article-title":"Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA\/J mice","volume":"181","author":"Beamer","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib124","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1002\/eji.201040433","article-title":"Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung","volume":"40","author":"Redford","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib125","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1128\/IAI.61.8.3482-3489.1993","article-title":"Cytokine production at the site of disease in human tuberculosis","volume":"61","author":"Barnes","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2012.12.002_bib126","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1046\/j.1365-2249.1999.00783.x","article-title":"Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment","volume":"115","author":"Verbon","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib127","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1128\/IAI.72.5.2628-2634.2004","article-title":"Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis","volume":"72","author":"Bonecini-Almeida","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2012.12.002_bib128","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/mi.2011.7","article-title":"The role of IL-10 in immune regulation during M.\u00a0tuberculosis infection","volume":"4","author":"Redford","year":"2011","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib129","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1128\/IAI.64.3.913-918.1996","article-title":"Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression","volume":"64","author":"Gong","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2012.12.002_bib130","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1006\/clim.1999.4752","article-title":"CD4 (+) T cell clones producing both interferon-gamma and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients","volume":"92","author":"Gerosa","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib131","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1172\/JCI9918","article-title":"IL-10-producing T cells suppress immune responses in anergic tuberculosis patients","volume":"105","author":"Boussiotis","year":"2000","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.micpath.2012.12.002_bib132","doi-asserted-by":"crossref","first-page":"15594","DOI":"10.1073\/pnas.0604283103","article-title":"A\u00a0deletion defining a common Asian lineage of Mycobacterium tuberculosis associates with immune subversion","volume":"103","author":"Newton","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micpath.2012.12.002_bib133","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1084\/jem.20101664","article-title":"Type I interferon: friend or foe?","volume":"207","author":"Trinchieri","year":"2010","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib134","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.4049\/jimmunol.0902065","article-title":"Type I IFN signaling constrains IL-17A\/F secretion by gammadelta T cells during bacterial infections","volume":"184","author":"Henry","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib135","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1084\/jem.20040976","article-title":"Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes","volume":"200","author":"Auerbuch","year":"2004","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib136","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1084\/jem.20040769","article-title":"Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection","volume":"200","author":"Carrero","year":"2004","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib137","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.1073\/pnas.091096998","article-title":"Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha\/beta","volume":"98","author":"Manca","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micpath.2012.12.002_bib138","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1089\/jir.2005.25.694","article-title":"tuberculosis W\/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway","volume":"25","author":"Manca","year":"2005","journal-title":"J\u00a0Interferon Cytokine Res"},{"key":"10.1016\/j.micpath.2012.12.002_bib139","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1172\/JCI40817","article-title":"Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte\/macrophage population","volume":"120","author":"Antonelli","year":"2010","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.micpath.2012.12.002_bib140","doi-asserted-by":"crossref","first-page":"6705","DOI":"10.4049\/jimmunol.178.11.6705","article-title":"Cutting edge: involvement of the type I IFN production and signaling pathway in lipopolysaccharide-induced IL-10 production","volume":"178","author":"Chang","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib141","doi-asserted-by":"crossref","first-page":"522","DOI":"10.4049\/jimmunol.179.1.522","article-title":"The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation","volume":"179","author":"Ordway","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib142","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1084\/jem.20091746","article-title":"Induction of IFN-alphabeta enables Listeria monocytogenes to suppress macrophage activation by IFN-gamma","volume":"207","author":"Rayamajhi","year":"2010","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib143","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature09247","article-title":"An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis","volume":"466","author":"Berry","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2012.12.002_bib144","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1473-3099(02)00182-2","article-title":"BCG\u2013different strains, different vaccines?","volume":"2","author":"Behr","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.micpath.2012.12.002_bib145","first-page":"27","article-title":"WHO position paper","volume":"79","author":"W.H.O. BCG vaccine","year":"2004","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.micpath.2012.12.002_bib146","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.micpath.2012.12.002_bib147","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1126\/science.284.5419.1520","article-title":"Comparative genomics of BCG vaccines by whole-genome DNA microarray","volume":"284","author":"Behr","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.micpath.2012.12.002_bib148","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1046\/j.1365-2958.1999.01383.x","article-title":"Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays","volume":"32","author":"Gordon","year":"1999","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.micpath.2012.12.002_bib149","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1128\/jb.178.5.1274-1282.1996","article-title":"Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis","volume":"178","author":"Mahairas","year":"1996","journal-title":"J\u00a0Bacteriol"},{"key":"10.1016\/j.micpath.2012.12.002_bib150","doi-asserted-by":"crossref","first-page":"12420","DOI":"10.1073\/pnas.1635213100","article-title":"The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue","volume":"100","author":"Hsu","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micpath.2012.12.002_bib151","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2567.2006.02427.x","article-title":"Mycobacteria lacking the RD1 region do not induce necrosis in the lungs of mice lacking interferon-gamma","volume":"119","author":"Junqueira-Kipnis","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.micpath.2012.12.002_bib152","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.4049\/jimmunol.174.6.3570","article-title":"Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system","volume":"174","author":"Majlessi","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib153","doi-asserted-by":"crossref","DOI":"10.1111\/j.1462-5822.2012.01799.x","article-title":"ESX-1-mediated translocation to the cytosol controls virulence of mycobacteria","author":"Houben","year":"2012","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.micpath.2012.12.002_bib154","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.cell.2007.05.059","article-title":"M.\u00a0tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells","volume":"129","author":"van der Wel","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.micpath.2012.12.002_bib155","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.4049\/jimmunol.178.5.3143","article-title":"The Type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis","volume":"178","author":"Stanley","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib156","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.chom.2012.03.007","article-title":"Mycobacterium tuberculosis activates the DNA-dependent cytosolic surveillance pathway within macrophages","volume":"11","author":"Manzanillo","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.micpath.2012.12.002_bib157","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nm859","article-title":"Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis","volume":"9","author":"Pym","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib158","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1086\/322042","article-title":"Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi","volume":"184","author":"Black","year":"2001","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.micpath.2012.12.002_bib159","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1128\/IAI.63.5.2033-2040.1995","article-title":"Influence of mouse strain and vaccine viability on T-cell responses induced by Mycobacterium bovis bacillus Calmette-Guerin","volume":"63","author":"Daugelat","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2012.12.002_bib160","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1128\/IAI.56.12.3310-3312.1988","article-title":"Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines","volume":"56","author":"Orme","year":"1988","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2012.12.002_bib161","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.0300-9475.2004.01471.x","article-title":"The influence of remaining live BCG organisms in vaccinated mice on the maintenance of immunity to tuberculosis","volume":"60","author":"Olsen","year":"2004","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib162","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/IAI.70.2.672-678.2002","article-title":"Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis","volume":"70","author":"Brandt","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2012.12.002_bib163","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/infdis\/jir515","article-title":"BCG vaccination induces different cytokine profiles following infant BCG vaccination in the UK and Malawi","volume":"204","author":"Lalor","year":"2011","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.micpath.2012.12.002_bib164","article-title":"Complex cytokine profiles induced by BCG vaccination in UK infants","author":"Lalor","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2012.12.002_bib165","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.4049\/jimmunol.180.5.3569","article-title":"Bacillus Calmette-Guerin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles","volume":"180","author":"Soares","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib166","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1365-2249.2006.03222.x","article-title":"The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette-Guerin vaccination in southern England and northern Malawi","volume":"146","author":"Weir","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib167","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1086\/597069","article-title":"Population differences in immune responses to Bacille Calmette-Guerin vaccination in infancy","volume":"199","author":"Lalor","year":"2009","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.micpath.2012.12.002_bib168","first-page":"200","article-title":"Does the efficacy of BCG decline with time since vaccination?","volume":"2","author":"Sterne","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.micpath.2012.12.002_bib169","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1001\/jama.291.17.2086","article-title":"Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: a 60-year follow-up study","volume":"291","author":"Aronson","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.micpath.2012.12.002_bib170","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(05)67145-0","article-title":"Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial","volume":"366","author":"Rodrigues","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.micpath.2012.12.002_bib171","doi-asserted-by":"crossref","first-page":"6946","DOI":"10.1128\/IAI.68.12.6946-6953.2000","article-title":"Genetically determined disparate innate and adaptive cell-mediated immune responses to pulmonary Mycobacterium bovis BCG infection in C57BL\/6 and BALB\/c mice","volume":"68","author":"Wakeham","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2012.12.002_bib172","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/infdis\/162.5.1216","article-title":"Disseminated bacille Calmette-Guerin infection in an AIDS patient 30 years after BCG vaccination","volume":"162","author":"Armbruster","year":"1990","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.micpath.2012.12.002_bib173","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/infdis\/160.4.727","article-title":"Bacille Calmette-Guerin adenitis 30 years after immunization in a patient with AIDS","volume":"160","author":"Reynes","year":"1989","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.micpath.2012.12.002_bib174","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1086\/513642","article-title":"Disseminated bacille Calmette-Guerin disease after vaccination: case report and review","volume":"24","author":"Talbot","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.micpath.2012.12.002_bib175","doi-asserted-by":"crossref","first-page":"13853","DOI":"10.1073\/pnas.250480397","article-title":"Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model","volume":"97","author":"Horwitz","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micpath.2012.12.002_bib176","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1172\/JCI24617","article-title":"Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin","volume":"115","author":"Grode","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.micpath.2012.12.002_bib177","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm.2285","article-title":"A\u00a0multistage tuberculosis vaccine that confers efficient protection before and after exposure","volume":"17","author":"Aagaard","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib178","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1086\/592450","article-title":"A\u00a0new recombinant bacille Calmette-Guerin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers","volume":"198","author":"Hoft","year":"2008","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.micpath.2012.12.002_bib179","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/nm906","article-title":"Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis","volume":"9","author":"Schaible","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib180","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1462-5822.2004.00408.x","article-title":"Apoptosis paves the detour path for CD8 T cell activation against intracellular bacteria","volume":"6","author":"Winau","year":"2004","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.micpath.2012.12.002_bib181","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.immuni.2005.12.001","article-title":"Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis","volume":"24","author":"Winau","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.micpath.2012.12.002_bib182","series-title":"ClinicalTrials.gov [Internet]","article-title":"Study to evaluate safety and immunogenicity of VPM1002 in comparison with BCG in newborn infants in South Africa","author":"Vakzine Projekt Management GmbH","year":"2000"},{"key":"10.1016\/j.micpath.2012.12.002_bib183","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1517\/14712598.8.2.201","article-title":"Live tuberculosis vaccines based on phoP mutants: a step towards clinical trials","volume":"8","author":"Asensio","year":"2008","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.micpath.2012.12.002_bib184","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.it.2012.03.004","article-title":"Tuberculosis vaccine development: strength lies in tenacity","volume":"33","author":"Kaufmann","year":"2012","journal-title":"Trends Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib185","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/nm.2420","article-title":"A\u00a0recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis","volume":"17","author":"Sweeney","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib186","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1128\/IAI.73.6.3814-3816.2005","article-title":"Boosting with poxviruses enhances Mycobacterium bovis BCG efficacy against tuberculosis in guinea pigs","volume":"73","author":"Williams","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2012.12.002_bib187","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1128\/IAI.69.2.681-686.2001","article-title":"Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis","volume":"69","author":"McShane","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2012.12.002_bib188","doi-asserted-by":"crossref","first-page":"e5264","DOI":"10.1371\/journal.pone.0005264","article-title":"MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques","volume":"4","author":"Verreck","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2012.12.002_bib189","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1128","article-title":"Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans","volume":"10","author":"McShane","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib190","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1164\/rccm.200809-1486OC","article-title":"Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals","volume":"179","author":"Sander","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib191","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1164\/rccm.201108-1548OC","article-title":"A\u00a0phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and\/or Mycobacterium tuberculosis-infected adults","volume":"185","author":"Scriba","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib192","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1002\/eji.200737504","article-title":"Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations","volume":"37","author":"Beveridge","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib193","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1128\/IAI.00004-07","article-title":"Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon","volume":"75","author":"Radosevic","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2012.12.002_bib194","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1586\/erv.11.28","article-title":"Tuberculosis vaccines in clinical trials","volume":"10","author":"Rowland","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.micpath.2012.12.002_bib195","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.4049\/jimmunol.173.10.6357","article-title":"Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis","volume":"173","author":"Wang","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib196","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/j.vaccine.2012.01.048","article-title":"A\u00a0recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity","volume":"30","author":"Hoft","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2012.12.002_bib197","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1164\/rccm.200910-1484OC","article-title":"The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults","volume":"181","author":"Abel","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib198","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1128\/IAI.00517-06","article-title":"Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis","volume":"74","author":"Santosuosso","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2012.12.002_bib199","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/mt.2009.130","article-title":"New insights on adenovirus as vaccine vectors","volume":"17","author":"Lasaro","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.micpath.2012.12.002_bib200","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ymthe.2004.07.013","article-title":"Adenoviruses as vaccine vectors","volume":"10","author":"Tatsis","year":"2004","journal-title":"Mol Ther"},{"key":"10.1016\/j.micpath.2012.12.002_bib201","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1128\/IAI.72.11.6622-6632.2004","article-title":"The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs","volume":"72","author":"Brandt","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2012.12.002_bib202","article-title":"Improved CD4 (+) T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72\/AS01 as compared to the M72\/AS02 and Mtb72F\/AS02 tuberculosis candidate vaccine formulations: a randomized trial","author":"Leroux-Roels","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2012.12.002_bib203","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1128\/CVI.00133-10","article-title":"Evaluation of the safety and immunogenicity of two antigen concentrations of the Mtb72F\/AS02(A) candidate tuberculosis vaccine in purified protein derivative-negative adults","volume":"17","author":"Leroux-Roels","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib204","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.4049\/jimmunol.177.9.6353","article-title":"Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity","volume":"177","author":"Dietrich","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib205","doi-asserted-by":"crossref","first-page":"6332","DOI":"10.4049\/jimmunol.174.10.6332","article-title":"Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy","volume":"174","author":"Dietrich","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib206","doi-asserted-by":"crossref","first-page":"53ra74","DOI":"10.1126\/scitranslmed.3001094","article-title":"A\u00a0defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis","volume":"2","author":"Bertholet","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib207","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/nm.2503","article-title":"Tuberculosis vaccine promises sterilizing immunity","volume":"17","author":"McShane","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib208","first-page":"191","article-title":"Effect of an immunomodulator containing Mycobacterium w on sputum conversion in pulmonary tuberculosis","volume":"100","author":"Patel","year":"2002","journal-title":"J\u00a0Indian Med Assoc"},{"key":"10.1016\/j.micpath.2012.12.002_bib209","first-page":"680","article-title":"Improved cure rates in pulmonary tuberculosis category II (retreatment) with mycobacterium w","volume":"101","author":"Patel","year":"2003","journal-title":"J\u00a0Indian Med Assoc"},{"key":"10.1016\/j.micpath.2012.12.002_bib210","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0140-6736(02)11141-X","article-title":"Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial","volume":"360","author":"Mwinga","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.micpath.2012.12.002_bib211","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0035-9203(00)90088-9","article-title":"Double-blind placebo-controlled trial of Mycobacterium vaccae immunotherapy for tuberculosis in KwaZulu, South Africa, 1991-97","volume":"94","author":"Mayo","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.micpath.2012.12.002_bib212","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1097\/00002030-200311070-00010","article-title":"Immunogenicity of an inactivated mycobacterial vaccine for the prevention of HIV-associated tuberculosis: a randomized, controlled trial","volume":"17","author":"Vuola","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.micpath.2012.12.002_bib213","doi-asserted-by":"crossref","first-page":"7652","DOI":"10.1016\/j.vaccine.2010.09.041","article-title":"Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: a phase III study in Tanzania","volume":"28","author":"Lahey","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2012.12.002_bib214","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/QAD.0b013e3283350f1b","article-title":"Prevention of tuberculosis in Bacille Calmette-Guerin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine","volume":"24","author":"von Reyn","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.micpath.2012.12.002_bib215","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1164\/rccm.201003-0334OC","article-title":"Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guerin vaccination of newborns","volume":"182","author":"Kagina","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib216","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib217","doi-asserted-by":"crossref","first-page":"12434","DOI":"10.1073\/pnas.0703510104","article-title":"Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis","volume":"104","author":"Mittrucker","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micpath.2012.12.002_bib218","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1128\/IAI.74.4.2128-2137.2006","article-title":"An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis","volume":"74","author":"Majlessi","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2012.12.002_bib219","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.1016\/j.vaccine.2009.06.103","article-title":"Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response","volume":"27","author":"Kagina","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2012.12.002_bib220","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1128\/CVI.00368-09","article-title":"Phenotypic definition of effector and memory T-lymphocyte subsets in mice chronically infected with Mycobacterium tuberculosis","volume":"17","author":"Henao-Tamayo","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib221","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1128\/IAI.70.8.4501-4509.2002","article-title":"Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity","volume":"70","author":"Chackerian","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2012.12.002_bib222","doi-asserted-by":"crossref","first-page":"10961","DOI":"10.1073\/pnas.0801496105","article-title":"ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes","volume":"105","author":"Reiley","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micpath.2012.12.002_bib223","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1084\/jem.20071367","article-title":"Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs","volume":"205","author":"Wolf","year":"2008","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib224","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1600-065X.2008.00693.x","article-title":"Early T-cell responses in tuberculosis immunity","volume":"225","author":"Winslow","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.micpath.2012.12.002_bib225","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/mi.2011.10","article-title":"Initiation and regulation of T-cell responses in tuberculosis","volume":"4","author":"Urdahl","year":"2011","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib226","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.171.3.1602","article-title":"Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara","volume":"171","author":"Goonetilleke","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib227","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1128\/IAI.70.3.1410-1416.2002","article-title":"Lymphocyte recruitment and protective efficacy against pulmonary mycobacterial infection are independent of the route of prior Mycobacterium bovis BCG immunization","volume":"70","author":"Palendira","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2012.12.002_bib228","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0192-0561(94)90033-7","article-title":"BCG-induced mucosal immune responses","volume":"16","author":"Gheorghiu","year":"1994","journal-title":"Int J Immunopharmacol"},{"key":"10.1016\/j.micpath.2012.12.002_bib229","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1128\/IAI.72.2.1065-1071.2004","article-title":"Paucibacillary tuberculosis in mice after prior aerosol immunization with Mycobacterium bovis BCG","volume":"72","author":"Nuermberger","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2012.12.002_bib230","doi-asserted-by":"crossref","first-page":"e8235","DOI":"10.1371\/journal.pone.0008235","article-title":"Immunization of mice with a recombinant adenovirus vaccine inhibits the early growth of Mycobacterium tuberculosis after infection","volume":"4","author":"Ronan","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2012.12.002_bib231","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.4049\/jimmunol.178.4.2387","article-title":"Mucosal luminal manipulation of T cell geography switches on protective efficacy by otherwise ineffective parenteral genetic immunization","volume":"178","author":"Santosuosso","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib232","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-065X.2008.00635.x","article-title":"Strategies for use of IL-10 or its antagonists in human disease","volume":"223","author":"O'Garra","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.micpath.2012.12.002_bib233","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1084\/jem.192.10.1529","article-title":"Anti-interleukin 10 receptor monoclonal antibody is an adjuvant for T helper cell type 1 responses to soluble antigen only in the presence of lipopolysaccharide","volume":"192","author":"Castro","year":"2000","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib234","doi-asserted-by":"crossref","first-page":"7620","DOI":"10.1128\/IAI.73.11.7620-7628.2005","article-title":"Interleukin-4 (IL-4) and IL-10 collude in vaccine failure for novel exacerbatory antigens in murine Leishmania major infection","volume":"73","author":"Roberts","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2012.12.002_bib235","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.4049\/jimmunol.175.4.2517","article-title":"IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection","volume":"175","author":"Stober","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib236","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1128\/IAI.73.8.4714-4722.2005","article-title":"Conditions influencing the efficacy of vaccination with live organisms against Leishmania major infection","volume":"73","author":"Tabbara","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2012.12.002_bib237","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1084\/jem.20092532","article-title":"IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platform","volume":"207","author":"Darrah","year":"2010","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib238","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1084\/jem.20071948","article-title":"IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection","volume":"205","author":"Brooks","year":"2008","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib239","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.4049\/jimmunol.1201061","article-title":"Blockade of IL-10 signaling during bacillus calmette-guerin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-gamma and IL-17 responses and increases protection to mycobacterium tuberculosis infection","volume":"189","author":"Pitt","year":"2012","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib240","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1073\/pnas.93.2.934","article-title":"Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guerin strains that secrete cytokines","volume":"93","author":"Murray","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micpath.2012.12.002_bib241","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.4049\/jimmunol.179.12.8418","article-title":"Improved protection against disseminated tuberculosis by Mycobacterium bovis bacillus Calmette-Guerin secreting murine GM-CSF is associated with expansion and activation of APCs","volume":"179","author":"Ryan","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib242","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1056\/NEJMra011223","article-title":"Vaccines and vaccination","volume":"345","author":"Ada","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micpath.2012.12.002_bib243","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1128\/CVI.00152-06","article-title":"Vaccines: all things considered","volume":"13","author":"Rosenthal","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.micpath.2012.12.002_bib244","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.vaccine.2009.09.134","article-title":"Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTI","volume":"28","author":"Vilaplana","year":"2010","journal-title":"Vaccine"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401012002070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401012002070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T12:08:02Z","timestamp":1714738082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401012002070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":244,"alternative-id":["S0882401012002070"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2012.12.002","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}